Clearside Biomedical to Participate in Three Upcoming Investor Conferences in August 2022
August 03 2022 - 7:05AM
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical
company revolutionizing the delivery of therapies to the back of
the eye through the suprachoroidal space (SCS®), announced today
that management will participate in the following investor
conferences in August 2022:
BTIG Biotechnology
ConferencePanel DiscussionTuesday, August 9, 2022 at 10:00
am ET New York,
NY
Wedbush PacGrow Healthcare Virtual
ConferenceFireside ChatWednesday, August 10, 2022 at 8:35
am ET
H.C. Wainwright 2nd Annual Ophthalmology
Virtual ConferencePanel Discussion and Corporate
PresentationWednesday, August 17, 2022 at 11:00 am ET
A link to available live and archived webcasts
may be accessed on the Clearside website under the Investors
section: Events and Presentations.
About Clearside Biomedical
Clearside Biomedical, Inc. is a
biopharmaceutical company revolutionizing the delivery of therapies
to the back of the eye through the suprachoroidal space (SCS®).
Clearside’s SCS injection platform, utilizing the Company’s
proprietary SCS Microinjector®, enables an in-office, repeatable,
non-surgical procedure for the targeted and compartmentalized
delivery of a wide variety of therapies to the macula, retina or
choroid to potentially preserve and improve vision in patients with
sight-threatening eye diseases. Clearside is developing its own
pipeline of small molecule product candidates for administration
via its SCS Microinjector and strategically partners its SCS
injection platform with companies utilizing other ophthalmic
therapeutic innovations. Clearside’s first product, XIPERE®
(triamcinolone acetonide injectable suspension) for suprachoroidal
use, is commercially available in the U.S. For more information,
please visit www.clearsidebio.com.
Investor and Media Contacts:Jenny
Kobin Remy Bernarda ir@clearsidebio.com(678) 430-8206
Source: Clearside Biomedical, Inc.
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
From Sep 2023 to Sep 2024